Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


09.07.2018

1 Am J Med
1 Am J Ophthalmol
2 Br J Ophthalmol
1 Circulation
1 Diabetes
1 Diabetes Care
1 Diabetes Educ
6 Diabetes Obes Metab
2 Diabetologia
2 Hypertension
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Med

  1. GEORGE C, Byun A, Howard-Thompson A
    New Injectable Agents for the Treatment of Type 2 Diabetes Part 2 - Glucagon like peptide-1 (GLP-1) agonists.
    Am J Med. 2018 Jun 30. pii: S0002-9343(18)30552.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  2. CALUGARU D, Calugaru M
    Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
    Am J Ophthalmol. 2018 Jun 30. pii: S0002-9394(18)30293.
    PubMed     Text format    


    Br J Ophthalmol

  3. MCKENNA M, Chen T, McAneney H, Vazquez Membrillo MA, et al
    Accuracy of trained rural ophthalmologists versus non-medical image graders in the diagnosis of diabetic retinopathy in rural China.
    Br J Ophthalmol. 2018 Jul 4. pii: bjophthalmol-2018-312440.
    PubMed     Text format     Abstract available

  4. BURNETT A, Lee L, D'Esposito F, Wabulembo G, et al
    Rapid assessment of avoidable blindness and diabetic retinopathy in people aged 50 years and older in the National Capital District of Papua New Guinea.
    Br J Ophthalmol. 2018 Jul 4. pii: bjophthalmol-2017-311803.
    PubMed     Text format     Abstract available


    Circulation

  5. SATTAR N, McGuire DK
    Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.
    Circulation. 2018;138:7-9.
    PubMed     Text format    


    Diabetes

  6. SANDRINE L, Sophie G, Alexis G, Franck L, et al
    A Humanized Mouse Model to Study Type 1 Diabetes.
    Diabetes. 2018 Jul 2. pii: db18-0202. doi: 10.2337/db18-0202.
    PubMed     Text format     Abstract available


    Diabetes Care

  7. JENKINS DA, Bowden J, Robinson HA, Sattar N, et al
    Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking.
    Diabetes Care. 2018 Jul 3. pii: dc17-2508. doi: 10.2337/dc17-2508.
    PubMed     Text format     Abstract available


    Diabetes Educ

  8. FREEMAN K, Hanlon M, Denslow S, Hooper V, et al
    Patient Engagement in Type 2 Diabetes: A Collaborative Community Health Initiative.
    Diabetes Educ. 2018 Jul 1:145721718784262. doi: 10.1177/0145721718784262.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  9. GUO L, Chen L, Chang B, Yang L, et al
    A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral
    Diabetes Obes Metab. 2018 Jul 2. doi: 10.1111/dom.13454.
    PubMed     Text format     Abstract available

  10. RIDDERSTRALE M, Rosenstock J, Andersen KR, Woerle HJ, et al
    Empagliflozin compared with glimepiride in metformin-treated patients with type 2 diabetes: 208-week data from a masked randomized controlled trial.
    Diabetes Obes Metab. 2018 Jul 2. doi: 10.1111/dom.13457.
    PubMed     Text format     Abstract available

  11. HARJUTSALO V, Thomas MC, Forsblom C, Groop PH, et al
    Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.
    Diabetes Obes Metab. 2018 Jul 2. doi: 10.1111/dom.13456.
    PubMed     Text format     Abstract available

  12. WANG JL, Dong YH, Ko WC, Chang CH, et al
    Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: a population-based cohort study.
    Diabetes Obes Metab. 2018 Jul 4. doi: 10.1111/dom.13461.
    PubMed     Text format     Abstract available

  13. ROSENSTOCK J, Handelsman Y, Vidal J, Ampudia Blasco FJ, et al
    Propensity score-matched comparative analyses of simultaneously administered fixed-ratio iGlarLixi (LixiLan) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes.
    Diabetes Obes Metab. 2018 Jul 4. doi: 10.1111/dom.13462.
    PubMed     Text format     Abstract available

  14. KADOWAKI T, Sarai N, Hirakawa T, Taki K, et al
    Persistence of oral antidiabetic treatment for type 2 diabetes characterized by drug class, patient characteristics, and severity of renal impairment: A Japanese database analysis.
    Diabetes Obes Metab. 2018 Jul 4. doi: 10.1111/dom.13463.
    PubMed     Text format    


    Diabetologia

  15. ERIKSSON JW, Lundkvist P, Jansson PA, Johansson L, et al
    Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
    Diabetologia. 2018 Jul 3. pii: 10.1007/s00125-018-4675.
    PubMed     Text format     Abstract available

  16. DU S, Wu X, Han T, Duan W, et al
    Dietary manganese and type 2 diabetes mellitus: two prospective cohort studies in China.
    Diabetologia. 2018 Jul 3. pii: 10.1007/s00125-018-4674.
    PubMed     Text format     Abstract available


    Hypertension

  17. KJELDSEN SE, Os I, Nilsson PM
    Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mm Hg in Patients With Diabetes Mellitus Participating in ACCORD?
    Hypertension. 2018 Jul 2. pii: HYPERTENSIONAHA.118.11455.
    PubMed     Text format    

  18. TSUJIMOTO T, Kajio H
    Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control.
    Hypertension. 2018 Jul 2. pii: HYPERTENSIONAHA.118.11408.
    PubMed     Text format     Abstract available


    PLoS One

  19. NGALA RA, Awe MA, Nsiah P
    The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study.
    PLoS One. 2018;13:e0197977.
    PubMed     Text format     Abstract available

  20. BESSER REJ, Ludvigsson J, Hindmarsh PC, Cole TJ, et al
    Exploring C-peptide loss in type 1 diabetes using growth curve analysis.
    PLoS One. 2018;13:e0199635.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  21. ZHANG H, Liu J, Qu D, Wang L, et al
    Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes.
    Proc Natl Acad Sci U S A. 2018 Jul 2. pii: 1721521115.
    PubMed     Text format     Abstract available


    Retina

  22. FENG Y, Zhu S, Skiadaresi E, McAlinden C, et al
    PHACOEMULSIFICATION CATARACT SURGERY WITH PROPHYLACTIC INTRAVITREAL BEVACIZUMAB FOR PATIENTS WITH COEXISTING DIABETIC RETINOPATHY: A Meta-Analysis.
    Retina. 2018 Jun 28. doi: 10.1097/IAE.0000000000002221.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: